Study found DNA-based screen was more than 90 percent accurate in predicting recurrence
This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
If testes don't descend, these males may need to be monitored for later malignancy
We care about your feedback. Let us know how we can improve your CancerCompass experience.